Colchicine to Reduce Atrial Fibrillation in the Postoperative Period of Myocardial Revascularization

Camila Stuchi Zarpelon, Miguel Chomiski Netto, José Carlos Moura Jorge, Cátia Carolina Fabris, Dieli Desengrini, Mariana da Silva Jardim, Diego Guedes da Silva, Camila Stuchi Zarpelon, Miguel Chomiski Netto, José Carlos Moura Jorge, Cátia Carolina Fabris, Dieli Desengrini, Mariana da Silva Jardim, Diego Guedes da Silva

Abstract

Background: The high prevalence of atrial fibrillation (AF) in the postoperative period of myocardial revascularization surgery increases morbidity and mortality.

Objective: To assess the efficacy of colchicine to prevent AF in the postoperative period of myocardial revascularization surgery, the impact of AF on hospital length of stay and death, and to identify its risk factors.

Methods: Between May 2012 and November 2013, 140 patients submitted to myocardial revascularization surgery were randomized, 69 to the control group and 71 to the colchicine group. Colchicine was used at the dose of 1 mg orally, twice daily, preoperatively, and of 0.5 mg, twice daily, until hospital discharge. A single dose of 1 mg was administered to those admitted 12 hours or less before surgery.

Results: The primary endpoint was AF rate in the postoperative period of myocardial revascularization surgery. Colchicine group patients showed no reduction in AF incidence as compared to control group patients (7.04% versus 13.04%, respectively; p = 0.271). There was no statistically significant difference between the groups regarding death from any cause rate (5.6% versus 10.1%; p = 0,363) and hospital length of stay (14.5 ± 11.5 versus 13.3 ± 9.4 days; p = 0.490). However, colchicine group patients had a higher infection rate (26.8% versus 8.7%; p = 0.007).

Conclusion: The use of colchicine to prevent AF after myocardial revascularization surgery was not effective in the present study. Brazilian Registry of Clinical Trials number RBR-556dhr.

Conflict of interest statement

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

References

    1. Zaman AG, Archbold A, Helft G, Paul EA, Curzen NP, Mills PG. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 2000;101(12):1403–1408.
    1. Nair SG. Atrial fibrillation after cardiac surgery. Ann Card Anaesth. 2010;13(3):196–205.
    1. Mitchell LB, CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society Atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can J Cardiol. 2011;27(1):91–97.
    1. Passannante AN. Prevention of atrial fibrillation after cardiac surgery. Curr Opin Anaesthsiol. 2011;24(1):58–63.
    1. Geovanini GR, Alves RJ, Brito GD, Miguel GA, Glauser VA, Nakiri K. Postoperative atrial fibrillation after cardiac surgery: Who should receive chemoprophylaxis? Arq Bras cardiol. 2009;92(4):326–330.
    1. Imazio M, Brucato A, Ferrazzi P, Rovere ME, Gandino A, Cemin R, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011;124(21):2290–2295.
    1. Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg. 2009;88(1):326–333.
    1. Ferro CR, Oliveira DC, Nunes FP, Piegas LS. Postoperative atrial fibrillation after cardiac surgery. Arq Bras Cardiol. 2009;93(1):59–63.
    1. Rostagno C. Recent developments in pharmacologic prophylaxis of atrial fibrillation in patients undergoing surgical revascularization. Cardiovasc Hematol Agents Med Chem. 2009;7(2):137–146.
    1. Olgin JE, Zipes DP. Braunwald E. Tratado de doenças cardiovasculares. 8ª ed. Rio de Janeiro: Elsevier; 2010. Arritmias específicas: diagnóstico e tratamento; pp. 863–931.
    1. Maisel WH, Rawn J, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135(12):106–173.
    1. Deftereos F, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K, et al. Colchicine and the heart: pushing the envelope. J Am Coll Cardiol. 2013;62(20):1817–1825.
    1. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, et al. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem. 2006;281(36):26391–26399.
    1. Malan D, Gallo MP, Bedendi I, Biasin C, Levi RC, Alloatti G. Microtubules mobility affects the modulation of L-type I(Ca) by muscarinic and beta-adrenergic agonists in guinea-pig cardiac myocytes. J Mol Cell Cardiol. 2003;35(2):195–206.
    1. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation. 1997;96(10):3542–3548.
    1. Hashemzadeh K, Dehdilani M, Dehdilani M. Does off-pump coronary artery bypass reduce the prevalence of atrial fibrillation? J Cardiovasc Thorac Res. 2013;5(2):45–49.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe